{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T23:20:21Z","timestamp":1789773621679,"version":"4.0.1"},"reference-count":50,"publisher":"American Society of Hematology","issue":"24","license":[{"start":{"date-parts":[[2024,3,17]],"date-time":"2024-03-17T00:00:00Z","timestamp":1710633600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,6,13]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>Pegylated interferon alfa (pegIFN-\u03b1) can induce molecular remissions in patients with JAK2-V617F\u2013positive myeloproliferative neoplasms (MPNs) by targeting long-term hematopoietic stem cells (LT-HSCs). Additional somatic mutations in genes regulating LT-HSC self-renewal, such as DNMT3A, have been reported to have poorer responses to pegIFN-\u03b1. We investigated whether DNMT3A loss leads to alterations in JAK2-V617F LT-HSC functions conferring resistance to pegIFN-\u03b1 treatment in a mouse model of MPN and in hematopoietic progenitors from patients with MPN. Long-term treatment with pegIFN-\u03b1 normalized blood parameters and reduced splenomegaly and JAK2-V617F chimerism in single-mutant JAK2-V617F (VF) mice. However, pegIFN-\u03b1 in VF;Dnmt3a\u0394\/\u0394 (VF;Dm\u0394\/\u0394) mice worsened splenomegaly and failed to reduce JAK2-V617F chimerism. Furthermore, LT-HSCs from VF;Dm\u0394\/\u0394 mice compared with VF were less prone to accumulate DNA damage and exit dormancy upon pegIFN-\u03b1 treatment. RNA sequencing showed that IFN-\u03b1 induced stronger upregulation of inflammatory pathways in LT-HSCs from VF;Dm\u0394\/\u0394 than from VF mice, indicating that the resistance of VF;Dm\u0394\/\u0394 LT-HSC was not due to failure in IFN-\u03b1 signaling. Transplantations of bone marrow from pegIFN-\u03b1\u2013treated VF;Dm\u0394\/\u0394 mice gave rise to more aggressive disease in secondary and tertiary recipients. Liquid cultures of hematopoietic progenitors from patients with MPN with JAK2-V617F and DNMT3A mutation showed increased percentages of JAK2-V617F\u2013positive colonies upon IFN-\u03b1 exposure, whereas in patients with JAK2-V617F alone, the percentages of JAK2-V617F\u2013positive colonies decreased or remained unchanged. PegIFN-\u03b1 combined with 5-azacytidine only partially overcame resistance in VF;Dm\u0394\/\u0394 mice. However, this combination strongly decreased the JAK2-mutant allele burden in mice carrying VF mutation only, showing potential to inflict substantial damage preferentially to the JAK2-mutant clone.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1182\/blood.2023020270","type":"journal-article","created":{"date-parts":[[2024,3,17]],"date-time":"2024-03-17T13:58:52Z","timestamp":1710683932000},"page":"2490-2503","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":20,"title":["Loss of\n                    <i>Dnmt3a<\/i>\n                    increases self-renewal and resistance to pegIFN-\u03b1 in\n                    <i>JAK2<\/i>\n                    -V617F\u2013positive myeloproliferative neoplasms"],"prefix":"10.1182","volume":"143","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-4575-8029","authenticated-orcid":false,"given":"Marc","family":"Usart","sequence":"first","affiliation":[{"name":"1Department of Biomedicine, Experimental Hematology, University Hospital Basel and University of Basel, Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4301-2856","authenticated-orcid":false,"given":"Jan","family":"Stetka","sequence":"additional","affiliation":[{"name":"1Department of Biomedicine, Experimental Hematology, University Hospital Basel and University of Basel, Basel, Switzerland"},{"name":"2Department of Biology, Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4523-675X","authenticated-orcid":false,"given":"Damien","family":"Luque Paz","sequence":"additional","affiliation":[{"name":"3University of Angers, Nantes Universit\u00e9, Centre Hospitalier Universitaire Angers, INSERM, Centre National de la Recherche Scientifique, Centre de Recherche en Canc\u00e9rologie et Immunologie Int\u00e9gr\u00e9e Nantes Angers, Angers, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nils","family":"Hansen","sequence":"additional","affiliation":[{"name":"1Department of Biomedicine, Experimental Hematology, University Hospital Basel and University of Basel, Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quentin","family":"Kimmerlin","sequence":"additional","affiliation":[{"name":"1Department of Biomedicine, Experimental Hematology, University Hospital Basel and University of Basel, Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiago","family":"Almeida Fonseca","sequence":"additional","affiliation":[{"name":"1Department of Biomedicine, Experimental Hematology, University Hospital Basel and University of Basel, Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Lock","sequence":"additional","affiliation":[{"name":"1Department of Biomedicine, Experimental Hematology, University Hospital Basel and University of Basel, Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Kubovcakova","sequence":"additional","affiliation":[{"name":"1Department of Biomedicine, Experimental Hematology, University Hospital Basel and University of Basel, Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riikka","family":"Karjalainen","sequence":"additional","affiliation":[{"name":"1Department of Biomedicine, Experimental Hematology, University Hospital Basel and University of Basel, Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Hao-Shen","sequence":"additional","affiliation":[{"name":"1Department of Biomedicine, Experimental Hematology, University Hospital Basel and University of Basel, Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasiya","family":"B\u00f6rsch","sequence":"additional","affiliation":[{"name":"4Department of Biomedicine, Bioinformatics, University of Basel and University Hospital Basel, Basel, Switzerland"},{"name":"5Swiss Institute of Bioinformatics, Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2424-8476","authenticated-orcid":false,"given":"Athimed","family":"El Taher","sequence":"additional","affiliation":[{"name":"4Department of Biomedicine, Bioinformatics, University of Basel and University Hospital Basel, Basel, Switzerland"},{"name":"5Swiss Institute of Bioinformatics, Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Schulz","sequence":"additional","affiliation":[{"name":"6Institute of Pharmaceutical Sciences, ETH Zurich, Zurich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5601-1292","authenticated-orcid":false,"given":"Jean-Christophe","family":"Leroux","sequence":"additional","affiliation":[{"name":"6Institute of Pharmaceutical Sciences, ETH Zurich, Zurich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Dirnhofer","sequence":"additional","affiliation":[{"name":"7Institute of Medical Genetics and Pathology, University Hospital Basel, Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3626-9496","authenticated-orcid":false,"given":"Radek C.","family":"Skoda","sequence":"additional","affiliation":[{"name":"1Department of Biomedicine, Experimental Hematology, University Hospital Basel and University of Basel, Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"6","key":"2024061315211902500_bib1","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1182\/blood-2016-10-695940","article-title":"Genetic basis and molecular pathophysiology of classical myeloproliferative neoplasms","volume":"129","author":"Vainchenker","year":"2017","journal-title":"Blood"},{"issue":"14","key":"2024061315211902500_bib2","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1182\/blood-2013-11-537167","article-title":"Clonal evolution and clinical correlates of somatic mutations in myeloproliferative neoplasms","volume":"123","author":"Lundberg","year":"2014","journal-title":"Blood"},{"issue":"9","key":"2024061315211902500_bib3","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1038\/leu.2014.76","article-title":"The number of prognostically detrimental mutations and prognosis in primary myelofibrosis: an international study of 797\u00a0patients","volume":"28","author":"Guglielmelli","year":"2014","journal-title":"Leukemia"},{"issue":"4","key":"2024061315211902500_bib4","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1200\/JCO.2017.76.4886","article-title":"MIPSS70: mutation-enhanced international prognostic score system for transplantation-age patients with primary myelofibrosis","volume":"36","author":"Guglielmelli","year":"2018","journal-title":"J\u00a0Clin Oncol"},{"issue":"15","key":"2024061315211902500_bib5","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1056\/NEJMoa1716614","article-title":"Classification and personalized prognosis in myeloproliferative neoplasms","volume":"379","author":"Grinfeld","year":"2018","journal-title":"N\u00a0Engl J Med"},{"issue":"19","key":"2024061315211902500_bib6","doi-asserted-by":"crossref","first-page":"4887","DOI":"10.1182\/bloodadvances.2020002271","article-title":"Leukemic evolution of polycythemia vera and essential thrombocythemia: genomic profiles predict time to transformation","volume":"4","author":"Luque Paz","year":"2020","journal-title":"Blood Adv"},{"issue":"26","key":"2024061315211902500_bib7","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1056\/NEJMoa1408617","article-title":"Age-related clonal hematopoiesis associated with adverse outcomes","volume":"371","author":"Jaiswal","year":"2014","journal-title":"N\u00a0Engl J Med"},{"issue":"26","key":"2024061315211902500_bib8","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1056\/NEJMoa1409405","article-title":"Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence","volume":"371","author":"Genovese","year":"2014","journal-title":"N\u00a0Engl J Med"},{"issue":"12","key":"2024061315211902500_bib9","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1038\/nm.3733","article-title":"Age-related mutations associated with clonal hematopoietic expansion and malignancies","volume":"20","author":"Xie","year":"2014","journal-title":"Nat Med"},{"issue":"7488","key":"2024061315211902500_bib10","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/nature13038","article-title":"Identification of pre-leukaemic haematopoietic stem cells in acute leukaemia","volume":"506","author":"Shlush","year":"2014","journal-title":"Nature"},{"issue":"7","key":"2024061315211902500_bib11","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1073\/pnas.1324297111","article-title":"Preleukemic mutations in human acute myeloid leukemia affect epigenetic regulators and persist in remission","volume":"111","author":"Corces-Zimmerman","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"2024061315211902500_bib12","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1038\/nrc3895","article-title":"DNMT3A in haematological malignancies","volume":"15","author":"Yang","year":"2015","journal-title":"Nat Rev Cancer"},{"issue":"4","key":"2024061315211902500_bib13","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.ccr.2014.02.010","article-title":"The R882H DNMT3A mutation associated with AML dominantly inhibits wild-type DNMT3A by blocking its ability to form active tetramers","volume":"25","author":"Russler-Germain","year":"2014","journal-title":"Cancer Cell"},{"issue":"5","key":"2024061315211902500_bib14","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.cell.2017.01.021","article-title":"CpG island hypermethylation mediated by DNMT3A is a consequence of AML progression","volume":"168","author":"Spencer","year":"2017","journal-title":"Cell"},{"issue":"1","key":"2024061315211902500_bib15","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/ng.1009","article-title":"Dnmt3a is essential for hematopoietic stem cell differentiation","volume":"44","author":"Challen","year":"2011","journal-title":"Nat Genet"},{"issue":"1","key":"2024061315211902500_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.celrep.2018.03.025","article-title":"Loss of Dnmt3a immortalizes hematopoietic stem cells in\u00a0vivo","volume":"23","author":"Jeong","year":"2018","journal-title":"Cell Rep"},{"issue":"4","key":"2024061315211902500_bib17","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.stemcr.2020.02.011","article-title":"Divergent effects of Dnmt3a and Tet2 mutations on hematopoietic progenitor cell fitness","volume":"14","author":"Ostrander","year":"2020","journal-title":"Stem Cell Reports"},{"issue":"8","key":"2024061315211902500_bib18","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1182\/blood-2008-03-143537","article-title":"Pegylated interferon-alfa-2a induces complete hematologic and molecular responses with low toxicity in polycythemia vera","volume":"112","author":"Kiladjian","year":"2008","journal-title":"Blood"},{"issue":"32","key":"2024061315211902500_bib19","doi-asserted-by":"crossref","first-page":"5418","DOI":"10.1200\/JCO.2009.23.6075","article-title":"Pegylated interferon alfa-2a yields high rates of hematologic and molecular response in patients with advanced essential thrombocythemia and polycythemia vera","volume":"27","author":"Quintas-Cardama","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"issue":"18","key":"2024061315211902500_bib20","doi-asserted-by":"crossref","first-page":"3692","DOI":"10.1182\/blood-2012-05-432989","article-title":"Depletion of Jak2V617F myeloproliferative neoplasm-propagating stem cells by interferon-alpha in a murine model of polycythemia vera","volume":"121","author":"Mullally","year":"2013","journal-title":"Blood"},{"issue":"8","key":"2024061315211902500_bib21","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1182\/blood-2013-04-498956","article-title":"JAK2V617F expression in mice amplifies early hematopoietic cells and gives them a competitive advantage that is hampered by IFNalpha","volume":"122","author":"Hasan","year":"2013","journal-title":"Blood"},{"issue":"4","key":"2024061315211902500_bib22","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1038\/s41375-019-0638-y","article-title":"Distinct effects of ruxolitinib and interferon-alpha on murine JAK2V617F myeloproliferative neoplasm hematopoietic stem cell populations","volume":"34","author":"Austin","year":"2020","journal-title":"Leukemia"},{"issue":"8","key":"2024061315211902500_bib23","doi-asserted-by":"crossref","first-page":"3931","DOI":"10.1182\/blood-2007-08-107748","article-title":"Ratio of mutant JAK2-V617F to wild-type Jak2 determines the MPD phenotypes in transgenic mice","volume":"111","author":"Tiedt","year":"2008","journal-title":"Blood"},{"issue":"6994","key":"2024061315211902500_bib24","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1038\/nature02633","article-title":"Essential role for de novo DNA methyltransferase Dnmt3a in paternal and maternal imprinting","volume":"429","author":"Kaneda","year":"2004","journal-title":"Nature"},{"issue":"2","key":"2024061315211902500_bib25","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1006\/cimm.2001.1895","article-title":"Observation of antigen-dependent CD8+ T-cell\/ dendritic cell interactions in\u00a0vivo","volume":"214","author":"Schaefer","year":"2001","journal-title":"Cell Immunol"},{"issue":"7","key":"2024061315211902500_bib26","doi-asserted-by":"crossref","first-page":"2724","DOI":"10.1182\/blood-2004-08-3037","article-title":"In\u00a0vivo fate-tracing studies using the Scl stem cell enhancer: embryonic hematopoietic stem cells significantly contribute to adult hematopoiesis","volume":"105","author":"Gothert","year":"2005","journal-title":"Blood"},{"issue":"10","key":"2024061315211902500_bib27","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1038\/ni978","article-title":"Cross-priming of CD8+ T cells stimulated by virus-induced type I interferon","volume":"4","author":"Le Bon","year":"2003","journal-title":"Nat Immunol"},{"issue":"7","key":"2024061315211902500_bib28","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1038\/s41375-022-01613-1","article-title":"The 5th edition of the World Health Organization classification of haematolymphoid tumours: myeloid and histiocytic\/dendritic neoplasms","volume":"36","author":"Khoury","year":"2022","journal-title":"Leukemia"},{"issue":"16","key":"2024061315211902500_bib29","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1182\/blood.2020005563","article-title":"JAK2-V617F and interferon-alpha induce megakaryocyte-biased stem cells characterized by decreased long-term functionality","volume":"137","author":"Rao","year":"2021","journal-title":"Blood"},{"issue":"45","key":"2024061315211902500_bib30","doi-asserted-by":"crossref","first-page":"42462","DOI":"10.1074\/jbc.C100466200","article-title":"ATM phosphorylates histone H2AX in response to DNA double-strand breaks","volume":"276","author":"Burma","year":"2001","journal-title":"J\u00a0Biol Chem"},{"issue":"7548","key":"2024061315211902500_bib31","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/nature14131","article-title":"Exit from dormancy provokes DNA-damage-induced attrition in haematopoietic stem cells","volume":"520","author":"Walter","year":"2015","journal-title":"Nature"},{"issue":"6","key":"2024061315211902500_bib32","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.stem.2016.08.007","article-title":"DNA damage-induced HSPC malfunction depends on ROS accumulation downstream of IFN-1 signaling and bid mobilization","volume":"19","author":"Tasdogan","year":"2016","journal-title":"Cell Stem Cell"},{"issue":"1-2","key":"2024061315211902500_bib33","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jim.2009.06.008","article-title":"ELDA: extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays","volume":"347","author":"Hu","year":"2009","journal-title":"J\u00a0Immunol Methods"},{"issue":"7687","key":"2024061315211902500_bib34","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/nature25168","article-title":"Clonal analysis of lineage fate in native haematopoiesis","volume":"553","author":"Rodriguez-Fraticelli","year":"2018","journal-title":"Nature"},{"issue":"6021","key":"2024061315211902500_bib35","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/315672a0","article-title":"Gamma-interferon transcriptionally regulates an early-response gene containing homology to platelet proteins","volume":"315","author":"Luster","year":"1985","journal-title":"Nature"},{"issue":"12","key":"2024061315211902500_bib36","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1084\/jem.187.12.2009","article-title":"Interferon-inducible T cell alpha chemoattractant (I-TAC): a novel non-ELR CXC chemokine with potent activity on activated T cells through selective high affinity binding to CXCR3","volume":"187","author":"Cole","year":"1998","journal-title":"J\u00a0Exp Med"},{"issue":"4","key":"2024061315211902500_bib37","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1189\/jlb.71.4.669","article-title":"IFN-alpha2a induces IP-10\/CXCL10 and MIG\/CXCL9 production in monocyte-derived dendritic cells and enhances their capacity to attract and stimulate CD8+ effector T cells","volume":"71","author":"Padovan","year":"2002","journal-title":"J\u00a0Leukoc Biol"},{"issue":"2","key":"2024061315211902500_bib38","doi-asserted-by":"crossref","first-page":"e20201268","DOI":"10.1084\/jem.20201268","article-title":"JAK2V617F myeloproliferative neoplasm eradication by a novel interferon\/arsenic therapy involves PML","volume":"218","author":"Dagher","year":"2021","journal-title":"J\u00a0Exp Med"},{"issue":"9","key":"2024061315211902500_bib39","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1038\/leu.2014.124","article-title":"DNMT3A and IDH mutations in acute myeloid leukemia and other myeloid malignancies: associations with prognosis and potential treatment strategies","volume":"28","author":"Im","year":"2014","journal-title":"Leukemia"},{"issue":"5","key":"2024061315211902500_bib40","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/j.cell.2015.07.011","article-title":"Inhibiting DNA methylation causes an interferon response in cancer via dsRNA including endogenous retroviruses","volume":"162","author":"Chiappinelli","year":"2015","journal-title":"Cell"},{"issue":"5","key":"2024061315211902500_bib41","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/s43018-021-00213-9","article-title":"Hotspot DNMT3A mutations in clonal hematopoiesis and acute myeloid leukemia sensitize cells to azacytidine via viral mimicry response","volume":"2","author":"Scheller","year":"2021","journal-title":"Nat Cancer"},{"issue":"26","key":"2024061315211902500_bib42","doi-asserted-by":"crossref","first-page":"2707","DOI":"10.1182\/blood-2018-04-846220","article-title":"Jak2V617F and Dnmt3a loss cooperate to induce myelofibrosis through activated enhancer-driven inflammation","volume":"132","author":"Jacquelin","year":"2018","journal-title":"Blood"},{"issue":"6","key":"2024061315211902500_bib43","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.ccr.2010.05.015","article-title":"Physiological Jak2V617F expression causes a lethal myeloproliferative neoplasm with differential effects on hematopoietic stem and progenitor cells","volume":"17","author":"Mullally","year":"2010","journal-title":"Cancer Cell"},{"issue":"7","key":"2024061315211902500_bib44","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1182\/blood-2012-03-415646","article-title":"Differential effects of hydroxyurea and INC424 on mutant allele burden and myeloproliferative phenotype in a JAK2-V617F polycythemia vera mouse model","volume":"121","author":"Kubovcakova","year":"2013","journal-title":"Blood"},{"issue":"6","key":"2024061315211902500_bib45","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1182\/blood-2012-07-442012","article-title":"Molecular analysis of patients with polycythemia vera or essential thrombocythemia receiving pegylated interferon alpha-2a","volume":"122","author":"Quintas-Cardama","year":"2013","journal-title":"Blood"},{"issue":"7","key":"2024061315211902500_bib46","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1182\/bloodadvances.2021004856","article-title":"Genomic profiling of a randomized trial of interferon-alpha vs hydroxyurea in MPN reveals mutation-specific responses","volume":"6","author":"Knudsen","year":"2022","journal-title":"Blood Adv"},{"issue":"7513","key":"2024061315211902500_bib47","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/nature13619","article-title":"Replication stress is a potent driver of functional decline in ageing haematopoietic stem cells","volume":"512","author":"Flach","year":"2014","journal-title":"Nature"},{"issue":"8","key":"2024061315211902500_bib48","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1016\/j.stem.2021.03.002","article-title":"Chronic infection drives Dnmt3a-loss-of-function clonal hematopoiesis via IFNgamma signaling","volume":"28","author":"Hormaechea-Agulla","year":"2021","journal-title":"Cell Stem Cell"},{"issue":"12","key":"2024061315211902500_bib49","doi-asserted-by":"crossref","first-page":"2763","DOI":"10.1158\/2159-8290.CD-22-0086","article-title":"Distinct tumor necrosis factor alpha receptors dictate stem cell fitness versus lineage output in Dnmt3a-mutant clonal hematopoiesis","volume":"12","author":"SanMiguel","year":"2022","journal-title":"Cancer Discov"},{"issue":"22","key":"2024061315211902500_bib50","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1101\/gad.313104","article-title":"c-Myc controls the balance between hematopoietic stem cell self-renewal and differentiation","volume":"18","author":"Wilson","year":"2004","journal-title":"Genes Dev"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/143\/24\/2490\/2228977\/blood_bld-2023-020270-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/143\/24\/2490\/2228977\/blood_bld-2023-020270-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T11:27:43Z","timestamp":1718278063000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/143\/24\/2490\/515323\/Loss-of-Dnmt3a-increases-self-renewal-and"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,13]]},"references-count":50,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2024,6,13]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.2023020270","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,13]]}}}